FULC
No price yet
Announcements
Nothing here yet
Daily updates
Nothing here yet
FDA designations
Nothing here yet
News
- Fulcrum Therapeutics reports positive 12-week data from the 20 mg cohort in the Phase 1b PIONEER trial of pociredir for sickle cell diseaseFeb 24, 2026
- Fulcrum Therapeutics planned to present 12-week data from the 20 mg cohort in the Phase 1b PIONEER trial of pociredir for sickle cell diseaseFeb 17, 2026
- Fulcrum Therapeutics announces results from the 12 mg dose cohort of Phase 1b PIONEER trial of Pociredir in sickle cell diseaseJul 29, 2025
- Fulcrum Therapeutics to present results from the 12 mg dose cohort of Phase 1b PIONEER trial of Pociredir in sickle cell diseaseJul 29, 2025